Four hundred seventeen squamous cell cancers in a heart transplant patient.

Squamous cell carcinoma (SCC) is the most common malignancy in organ transplant recipients. In this patient population it pursues a much more aggressive course than in the general population: it occurs with higher frequency and displays a greater tendency to recur locally and metastasize, even after surgical excision. Hence, prophylactic measures assume a very important role in these patients. Patients should minimize their sun exposure and have their skin examined routinely. For those with large numbers of SCCs, systemic retinoids and reduction in immunosuppressive regimen may be of benefit. We present the case of a 70-year-old male heart transplant recipient who developed 334 SCCs, 83 SCCs in situ, and innumerable actinic keratoses during the course of 19 years posttransplant. His cancerous lesions were all excised surgically, but over the years, his cancer assumed a progressively more aggressive course. His immunosuppressive regimen was eventually reduced.
AuthorsAllen S Liu, Elof Eriksson
JournalAnnals of plastic surgery (Ann Plast Surg) Vol. 67 Issue 5 Pg. 545-6 (Nov 2011) ISSN: 1536-3708 [Electronic] United States
PMID22001423 (Publication Type: Case Reports, Journal Article)
  • Aged
  • Carcinoma, Squamous Cell (etiology, pathology)
  • Heart Transplantation (adverse effects)
  • Humans
  • Male
  • Skin Neoplasms (etiology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: